Tricare Now Screening Compound Medications as of May 1st
Effective May 1, Tricare pharmacy contractor Express Scripts began screening each ingredient in compound medications to ensure all are approved by the Food and Drug Administration.
From the Military Times - "An allowance in Tricare's prescription drug coverage policy that has drained nearly $1 billion from the Pentagon's health budget since January will vanish Friday when a new policy on compound medications goes into effect.
Under the new process, many patients who use personalized drug formulas still will have access to their medications, said Dr. George Jones, Tricare's pharmacy chief.
But others — including some who ordered prescriptions directly from compounding pharmacies in recent months —may need to work with their pharmacists to ensure their prescriptions comply with the new requirements or receive prior authorization for coverage."
Please click here to read the entire Military Times article.
Military Times Commentary: "Compound Medications Can Benefit Patients"
In an editorial to Military Times, Dr. Randy Lundell, a family physician in Utah, who has served seven years in uniform, including a tour in Iraq, says compound medications, used carefully, can be of great benefit to some patients.
"As a physician and a veteran who works closely with compounding pharmacies on behalf of my patients, I found that the accusations in the April 10 Military Times article, 'Compound Pharmacies Marketing Directly to Tricare Users,' painted an unfair picture of the overall industry.
A few bad actors can do a lot of damage, but I can assure you that these aggressive marketing practices are spearheaded by the minority.
As the head physician for a clinic that focuses a great deal on family, sport, pediatric, and women's health, I have worked with many patients who need compounded bio-identical hormone replacement therapy — whether it be to help them conceive a child, alleviate complications from menopause or to treat symptoms of post-ovarian cancer."
Please click here to read the entire article.
Potential CBS News Story to Run
Late last week, IACP learned that CBS News may be broadcasting a follow-up to its late February coverage of a compounding pharmacy that allegedly billed more than $18,000 for three compounds through questionable marketing alliances. Click here for the February story.
It reportedly goes further than the previous story and from our sources, it identifies a Tricare beneficiary who was contacted by a marketing company, was prescribed an expensive compound, attempted to cancel/refused the prescription, and Tricare was billed. There is supposed to be considerable focus on the prescribing doctor out of California. We do not know at this time whether it is the same pharmacy or a different pharmacy.
The new broadcast was to have broadcasted last Friday; but, appears to have been pre-empted by breaking news. IACP will continue to monitor for the CBS News broadcast, and will issue message points to our members should the story warrant them.
Please be aware that the 2016 National Defense Authorization Act (NDAA) currently is being addressed in Congress. The timing for this CBS News story could have impact on that legislative process. IACP is watching very carefully, and will keep our members apprised of any developments. Please email IACP at firstname.lastname@example.org with any questions.
IACP Presents Pharmacist Compounding Concerns At FDA Stakeholder Meeting
The Food & Drug Administration (FDA) invited IACP to participate in a Pharmacy Compounding Stakeholder meeting held on April 30, 2015 at their White Oak Campus in Silver Spring, Md.
The FDA has been holding a series of listening sessions with groups of interested stakeholders to discuss FDA’s efforts to implement the compounding provisions of the Drug Quality and Security Act (DQSA), signed into law in November, 2013.
IACP's David G. Miller, RPh, Executive Vice President/CEO and Cynthia Blankenship, Esq., Vice President of Government Affairs attended the meeting, and presented the pharmacist compounding community's concerns regarding DQSA's enactment.
Please click here to read IACP's Issues and Concerns of the Compounding Pharmacist Community submitted for last week's session with the FDA.
Texas Supreme Court States Office-Use is a Dispensing Activity
In a closely watched case for compounders, the Texas Supreme Court upheld both that pharmacists and compounding are covered under the state's Medical Liability Act as well as confirms that the practice of office-use as provided for within Texas Law are considered "dispensing."
Accordingly, we hold that a pharmacist who compounds a drug for office use pursuant to a practitioner’s lawful order, as authorized by the Pharmacy Act, is “dispensing” the drug whether or not the order identifies the patients to whom the drug will be administered.
Copy of the Ruling
The case is Randol Mill Pharmacy, et. al., v. Miller. Please click here for a copy of the ruling.
This ruling is especially pertinent in light of the ongoing interpretation by the FDA that office-use is not a dispensing activity and is prohibited by the Drug Quality & Security Act.
Please email IACP at email@example.com with questions.
College of Psychiatric and Neurologic Pharmacists Releases Practical Guidelines on Naloxone Access for Pharmacists
The College of Psychiatric & Neurologic Pharmacists (CPNP) and members of its Substance Abuse Task Force have announced the release of a guideline document intended to educate pharmacists on naloxone use and administration with the goal of providing increased patient access to this life‐saving medication for opioid overdose.
NALOXONE ACCESS: A Practical Guideline for Pharmacists, provides information on the following:
How Naloxone is Supplied
Prescribing and Dispensing
Acquisition and Reimbursement
Supporting Laws and Regulations
Frequently Asked Questions (FAQs)
Patient Information Sheets for both Intranasal and Intramuscular Administration of Naloxone
Please click here for more information.
IACP Provides You with the Latest State Updates!
IACP Members: Check out the latest state news on IACP's Compounders Stateside page. We've also added a new State Legislation Tracker on Pharmacy Provider Status. Click here to view!
2015 State Board of Pharmacy Meeting Schedule - please click here to view.
New IACP Corporate Partners
Welcome new Corporate Partners: Fagron Academy, Regulatory Compliance Associates, Inc., and TherapeuticsMD! Learn more about these Corporate Partners by clicking on their respective logos, below.
IACP's award-winning Corporate Partner program engages corporate leaders in the pharmacy compounding community by connecting them with IACP’s more than 4,000 Members. We encourage all IACP Members to support these corporate partners that are instrumental in our joint effort to protect and grow this vital part of quality health care. If you are interested in becoming a Corporate Partner, click here and email your completed form to IACP's Ashlyn Grant or by fax to (281) 495-0602.
Please visit IACP's Corporate Partners webpage here.
ACHC and IACP Announce Partnership
Accreditation Commission for Health Care (ACHC) has announced a newly formed partnership with the International Academy of Compounding Pharmacists (IACP). The partnership between the two organizations allows IACP to provide its compounding pharmacy members with special pricing for ACHC’s nationally recognized PCAB accreditation and resources.
“IACP plays a significant role in supporting compounding pharmacies and we believe this partnership will enhance the ability for ACHC to offer relevant compliance solutions and educational resources to compounding pharmacies,” said Matt Hughes, ACHC Director of Business Development and Customer Service. "ACHC is eager to begin growing our new partnership with IACP and we look forward to the many future opportunities our organizations have ahead of us.”
“IACP is proud to partner with Accreditation Commission for Health Care,” said, IACP President Dale Coker, RPh, FIACP. “We deeply value the role accreditation plays in the development of a compounding pharmacy. Over the last several years, IACP has appreciated its long-standing relationship with PCAB, which now has become a part of ACHC. We look forward to the continuing advancement of this organization, and its ability to provide IACP Members with a meaningful resource to help achieve their accreditation goals.”
Please click here to view the press release announcement.
LAST CALL: Comment Period Ends on May 31st for USP's Revised Chapter of the Proposed <800>
The United States Pharmacopeial Convention (USP) announces that the revised chapter of the proposed <800> is now posted on the USP website. Please click here to review.
The chapter will still be proposed in the Pharmacopeial Forum 41(2) in Mar/April 2015. The comment period for this chapter will end on May 31st, 2015.